Home
Markets
Charts & Ideas
Algo
News
Store
Brokers
Download
Economic Calendar
Trading Signals
WebTerminal
Heatmap
Type
/
to search: @user, $symbol
Search
Log in
Create an account
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
CELU
#4293
Celularity Inc. - Class A Common Stock
1.5
8
USD
-0.25%
Market Price
Sector:
Healthcare
Base:
USD
Profit Currency:
USD
Daily Range
Year Range
Daily Change
-24.76%
Monthly Change
+132.35%
6 month change
+28.46%
Year Change
-49.03%
Previous Close
2.1
0
Open
1.5
8
Low
1.5
8
High
1.5
8
Volume
5
Markets
US Stock Market
Healthcare
Biotechnology
CELU
1D
1W
1M
3M
6M
YTD
1Y
5Y
Open full chart
Financials
Overview
Statement
Statistics
Documents
2024
Current report, Q3 FY2024
2024.08.05
Celularity Inc current report, Q3 FY2024
8-K
Current report, Q3 FY2024
2024.09.13
Celularity Inc current report, Q3 FY2024
8-K
Quarterly report, Q2 FY2024
2024.11.07
Celularity Inc quarterly report, Q2 FY2024
10-Q
1
2
3
4
5
6
News
Why Is Celularity Stock Gaining Thursday? - Celularity (NASDAQ:CELU)
Penny Stocks: Why Is Celularity (CELU) Stock Trending Today? - TipRanks.com
NEXGEL discloses $15M upfront payment for Celularity portfolio
NexGel to license, acquire regenerative biomaterial products
Celularity licenses biomaterials portfolio for up to $35 million
Celularity names John Sprague acting CFO following executive departure
Celularity receives $12.2 million from sale of tax credits
Celularity stock drops after CMS withdraws skin substitute LCDs
Medicare withdraws skin substitute coverage changes set for 2026
Celularity secures $10 million financing from DoubleLine co-founder
Celularity secures up to $12 million in financing for longevity focus
Celularity’s diabetic foot ulcer therapy shows promise in clinical trial